- Home
- PRSU vs SYRE Comparison
PRSU vs SYRE Comparison
Compare PRSU & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRSU
- SYRE
- Stock Information
- Founded
- PRSU 1926
- SYRE 2013
- Country
- PRSU United States
- SYRE United States
- Employees
- PRSU N/A
- SYRE N/A
- Industry
- PRSU Business Services
- SYRE Biotechnology: Pharmaceutical Preparations
- Sector
- PRSU Consumer Discretionary
- SYRE Health Care
- Exchange
- PRSU Nasdaq
- SYRE Nasdaq
- Market Cap
- PRSU 999.2M
- SYRE 1.1B
- IPO Year
- PRSU N/A
- SYRE 2016
- Fundamental
- Price
- PRSU $36.64
- SYRE $15.65
- Analyst Decision
- PRSU Strong Buy
- SYRE Buy
- Analyst Count
- PRSU 3
- SYRE 5
- Target Price
- PRSU $29.67
- SYRE $55.00
- AVG Volume (30 Days)
- PRSU 207.0K
- SYRE 455.6K
- Earning Date
- PRSU 08-06-2025
- SYRE 11-06-2025
- Dividend Yield
- PRSU N/A
- SYRE N/A
- EPS Growth
- PRSU 1138.43
- SYRE N/A
- EPS
- PRSU 9.98
- SYRE N/A
- Revenue
- PRSU $382,378,000.00
- SYRE N/A
- Revenue This Year
- PRSU $22.00
- SYRE N/A
- Revenue Next Year
- PRSU $8.35
- SYRE N/A
- P/E Ratio
- PRSU $3.67
- SYRE N/A
- Revenue Growth
- PRSU 4.63
- SYRE N/A
- 52 Week Low
- PRSU $26.66
- SYRE $10.91
- 52 Week High
- PRSU $47.49
- SYRE $40.26
- Technical
- Relative Strength Index (RSI)
- PRSU 57.75
- SYRE 40.69
- Support Level
- PRSU $35.74
- SYRE $15.80
- Resistance Level
- PRSU $38.13
- SYRE $17.58
- Average True Range (ATR)
- PRSU 0.88
- SYRE 0.75
- MACD
- PRSU -0.23
- SYRE -0.12
- Stochastic Oscillator
- PRSU 35.02
- SYRE 0.52
About PRSU Pursuit Attractions and Hospitality Inc. Common Stock
Pursuit Attractions and Hospitality Inc is an attractions and hospitality company that owns and operates a collection of inspiring and unforgettable experiences at iconic destinations across the United States, Canada, and Iceland. Its elevated hospitality offerings include point-of-interest attractions and distinctive lodges, as well as integrated restaurants, retail options, and transportation that allow visitors to discover and connect with breathtaking national parks and renowned travel locations.
About SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.